Universal monitoring of minimal residual disease in acute myeloid leukemia

BACKGROUND. Optimal management of acute myeloid leukemia (AML) requires monitoring of treatment response, but minimal residual disease (MRD) may escape detection. We sought to identify distinctive features of AML cells for universal MRD monitoring. METHODS. We compared genome-wide gene expression of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Coustan-Smith, Elaine, Song, Guangchun, Shurtleff, Sheila, Yeoh, Allen Eng-Juh, Chng, Wee Joo, Chen, Siew Peng, Rubnitz, Jeffrey E., Pui, Ching-Hon, Downing, James R., Campana, Dario
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2018
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012500/
https://ncbi.nlm.nih.gov/pubmed/29720577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98561
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados